unh-20260127
0000731766
false
0000731766
2026-01-27
2026-01-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM 
8-K
 
—————————————
Current Report 
Pursuant to Section 13 or 15(d) of 
The Securities Exchange Act of 1934 
Date of report (Date of earliest event reported): 
January 27, 2026
 
—————————————
UNITEDHEALTH GROUP INCORPORATED
 
(Exact name of registrant as specified in its charter) 
—————————————
Delaware
1-10864
41-1321939
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
1 Health Drive
655 New York Avenue NW
Eden Prairie,
Minnesota
55344
Washington,
DC
20001
(Address of principal executive offices)
(Zip Code)
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (
800
) 
328-5979
 
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
☐
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
UNH
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
☐
Item 2.02
    
Results of Operations and Financial Condition.
On January 27, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference. 
The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. 
Item 9.01.
    
Financial Statements and Exhibits.
Exhibit
Description
99.1
Press Release dated January 27, 2026
99.2
Hyperlinked PDF
104
Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 27, 2026                 
UNITEDHEALTH GROUP INCORPORATED
By:
 /s/ Kuai H. Leong
Kuai H. Leong
Senior Deputy General Counsel and Deputy Corporate Secretary